QuantLogix

ABBV vs BMY — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

engine lead
ABBV
ABBVIE INC.
69/100
STRONG BUY
$250.09 · +0.85% · $438.2B
58% of similar setups up in 5d
Full scorecard →
VS
BMY
Bristol-Myers Squibb Co.
59/100
BUY
$63.61 · -1.31% · $132.4B
54% of similar setups up in 5d
Full scorecard →
Factor by factor — ABBV (left) vs BMY (right)
63
Technical
64
56
Momentum
54
85
Fundamental
82
65
Options
31
80
Microstructure
53

QuantLogix's 5-factor engine currently reads ABBVIE INC. (ABBV) at 69/100 (strong buy) and Bristol-Myers Squibb Co. (BMY) at 59/100 (buy). ABBV carries the stronger composite read by 10 points, led by fundamental at 85/100. BMY's strongest leg is fundamental at 82/100. In pattern backtesting, 58% of 50 ABBV setups and 54% of 50 BMY setups rose within five trading days. Signals recompute throughout the trading day — the balance can shift with the tape.

Track ABBV with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. ABBV scorecard · BMY scorecard · ABBV earnings · BMY earnings · Today's movers · Verified track record